Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Platelet Transfusion and Repeat Thromboelastography With Platelet Mapping (TEG-PM) in Patients With Severe Traumatic Brain Injuries (TBI) on Antiplatelet Therapy

NCT06433622 is registered in ClinicalTrials.gov with Lancaster General Hospital as lead sponsor.

NCT NCT06433622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06433622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Platelet Transfusion and Repeat Thromboelastography With Platelet Mapping (TEG-PM) in Patients With Severe Traumatic Brain Injuries (TBI) on Antiplatelet Therapy
Lead sponsor
Lancaster General Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
December 1, 2023
Completion date
November 30, 2027
Enrollment
225 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic intracranial hemorrhage